IP Library Granted Patent US 7,962,204
Granted Patent B2
US 7,962,204 · App. 12/273,383 · Granted Jun 14, 2011

Method of recommending neurophysiological therapies

Assignee: CNS Response, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,962,204
App. No.
12/273,383
Granted
Jun 14, 2011
Kind
B2
Abstract

A method and system for utilizing neurophysiologic information obtained by techniques such as quantitative electroencephalography (QEEG), electrode recordings, MRI in appropriately matching patients with therapeutic entities is disclosed. The present invention enables utilization of neurophysiologic information, notwithstanding its weak correlation with extant diagnostic schemes for mental disorders, for safer and expeditious treatment for mental disorders, discovering new applications for therapeutic entities, improved testing of candidate therapeutic entities, inferring the presence or absence of a desirable response to a treatment, and deducing the mode of action of one or more therapeutic entities. In particular, methods for effectively comparing neurophysiologic information relative to a reference set are disclosed along with database-based tools for deducing therapeutic entity actions on particular patients such that these tools are readily accessible to remote users.

Claims (17)

1. A method for recommending treatment, comprising:

a) providing;

i) a first set of quantified neurophysiologic information obtained from a patient having a behaviorally diagnosed psychiatric disorder;

ii) a second set of quantified neurophysiologic information obtained from at least one reference population of individuals, wherein said second information set comprises at least one therapy responsivity profile, wherein said profile includes a first treatment modality, wherein said first treatment modality is recommended independently of said diagnosed psychiatric disorder and associated symptoms;

b) comparing said first set of quantified neurophysiologic information with said second set of quantified neurophysiologic information by cluster analysis, under conditions such that a correlation between said patient and said at least one therapy responsivity profile is indicated, wherein said comparing is performed by a computer;

c) recommending said first treatment modality for said patient based upon said indicated correlation.

2. The method of claim 1 , wherein said therapy responsivity profile comprises determined effects of said at least one treatment modality.

3. The method of claim 1 , wherein said indicated correlation comprises a relatively high correlation such that said at least one reference population was relatively effectively treated with said at least one treatment modality.

4. The method of claim 1 , wherein said indicated correlation comprises a relatively low correlation such that said at least one reference population was relatively ineffectively treated with said at least one treatment modality.

5. The method of claim 1 , further comprising repeating step (b) and step (c) after administering said first treatment modality to said patient, wherein said repeated step (c) recommends a second treatment modality.

6. The method of claim 1 , wherein said first and second sets of quantified neurophysiological information comprise electroencephalographic information.

7. The method of claim 6 , wherein said electroencephalographic information was recorded by electrodes placed in accordance with the International 10/20 system.

8. The method of claim 1 , wherein said behaviorally diagnosed psychiatric disorder is selected from the group consisting of a major depressive disorder, a psychosomatic disorder, an atypical asthma disorder, an anxiety disorder, infancy disorders, childhood disorders, adolescence disorders, eating disorders, delirium disorders, dementia disorders, amnestic disorders, general cognitive disorders, impulse control disorders, mood disorders, personality disorders, hypoactive sexual desire disorders, sleep disorders, somatoform disorders, and substance-related disorders.

9. The method of claim 1 , wherein said treatment modality is selected from the group consisting of psychiatric therapy, including for example therapeutic entity therapy, medicinal therapy, psychotherapy, verbal therapy, convulsive therapy, neuromodulation therapy, electromagnetic therapy, and photo therapy.

10. The method of claim 1 , wherein said recommending comprises a report identifying said least one treatment modality as a plurality of agent classes and a list of specific agents within each of said classes.

11. The method of claim 10 , wherein said agent classes are in order of significance.

12. The method of claim 10 , wherein said specific agents are in order of responsivity.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2019
From: MYND ANALYTICS, INC.
To: MYND ANALYTICS, INC., A CALIFORNIA CORPORATION
Reel/Frame 049713/0079 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2018
From: CNS RESPONSE, INC.
To: MYND ANALYTICS, INC.
Reel/Frame 046347/0417 →
CHANGE OF NAME Recorded Feb 26, 2016
From: CNS RESPONSE, INC.
To: MYND ANALYTICS, INC.
Reel/Frame 037940/0531 →
SECURITY INTEREST Recorded May 15, 2015
From: CNS RESPONSE, INC.
To: RSJ PRIVATE EQUITY INVESTICNI FOND S PROMENNYM ZAKLADNIM KAPITALEM A.S. AS REPRESENTATIVE SECURED PARTY
Reel/Frame 035650/0884 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2010
From: SUFFIN, STEPHEN C.; EMORY, W. HAMLIN; BRANDT, LEONARD J.
To: CNS RESPONSE, INC.
Reel/Frame 023907/0761 →
Continuity (4)
Division 11605585 · Nov 29, 2006
Division 10193735 · Jul 11, 2002
Provisional Application 60304628 · Jul 11, 2001
Related Publication 20090137923A1 · May 28, 2009